23/07/2021 - 13:30

BARD1 raises $15m for cancer detection tests

23/07/2021 - 13:30

Bookmark

Save articles for future reference.

BARD1 Life Sciences has secured funds from a share placement to develop tests focused on the early detection of ovarian and breast cancer.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options